We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+14.54%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$2.47B
AUM Growth
-$118M
Cap. Flow
-$497M
Cap. Flow %
-20.15%
Top 10 Hldgs %
35.06%
Holding
147
New
13
Increased
26
Reduced
28
Closed
38

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$70.1M
2
ADPT
Adeptus Health Inc
ADPT
+$48.6M
3
FPRX
Five Prime Therapeutics, Inc.
FPRX
+$22.8M
4
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$17.2M
5
XNPT
XENOPORT, INC.
XNPT
+$15.9M

Top Sells

Rank Stock Value
1
BLUE
bluebird bio
BLUE
+$41.3M
2
NXTM
NxStage Medical Inc.
NXTM
+$32.2M
3
ELGX
Endologix Inc
ELGX
+$28.8M
4
GSK icon
GSK
GSK
+$24.8M
5
LOXO
Loxo Oncology, Inc
LOXO
+$22.5M

Sector Composition

Rank Sector Weight
1 Healthcare 68.33%
2 Financials 4.33%
3 Technology 0.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TCON
76
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$4.48M 0.18%
2,425
– –
GNCA
77
DELISTED
Genocea Biosciences, Inc.
GNCA
$4.41M 0.18%
104,657
+42,000
+67% +$2M
STDY
78
DELISTED
SteadyMed Ltd
STDY
$4.39M 0.18%
1,346,744
+31,575
+2% +$95.1K
SCYX icon
79
SCYNEXIS
SCYX
$42.4M
$4.32M 0.18%
8,704
+44
+0.5% +$23.2K
ADYX
80
DELISTED
Adynxx Inc
ADYX
$4.02M 0.16%
31,336
+3,377
+12% +$577K
GEN
81
DELISTED
Genesis Healthcare, Inc.
GEN
$3.34M 0.14%
963,564
-574,668
-37% -$2.75M
IMMU
82
DELISTED
Immunomedics Inc
IMMU
$3.3M 0.13%
+1,073,640
New +$3M
TRIB
83
Trinity Biotech
TRIB
$6.79M
$2.89M 0.12%
49,200
– –
VCYT icon
84
Veracyte
VCYT
$4.72B
$2.82M 0.11%
392,147
+8,891
+2% +$59.9K
CTIC
85
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$2.75M 0.11%
+223,683
New +$2.99M
ACUR
86
DELISTED
Acura Pharmaceuticals
ACUR
$2.56M 0.1%
1,025,641
– –
TRIL
87
DELISTED
Trillium Therapeutics Inc.
TRIL
$2.17M 0.09%
172,307
– –
CDTX
88
DELISTED
Cidara Therapeutics
CDTX
$2.05M 0.08%
5,973
-5,906
-50% -$1.77M
ELV icon
89
Elevance Health
ELV
$80.9B
$2.04M 0.08%
14,649
-126,157
-90% -$17.4M
ATEC icon
90
Alphatec Holdings
ATEC
$1.31B
$1.5M 0.06%
415,228
– –
CDNA icon
91
CareDx
CDNA
$2.05B
$1.47M 0.06%
229,000
– –
APYX icon
92
Apyx Medical
APYX
$180M
$1.45M 0.06%
688,229
– –
PTN
93
Palatin Technologies
PTN
$16.2M
$1.33M 0.05%
1,600
– –
STRM
94
DELISTED
Streamline Health Solutions
STRM
$935K 0.04%
44,198
-107,319
-71% -$2.91M
RNVA
95
DELISTED
Rennova Health, Inc.
RNVA
$755K 0.03%
+1,243
New +$2.15M
COR icon
96
Cencora
COR
$59.9B
$311K 0.01%
+3,000
New +$295K
POZN
97
DELISTED
POZEN INC
POZN
$305K 0.01%
44,583
– –
BHC icon
98
Bausch Health
BHC
$1.8B
– –
-1,575
Closed -$281K
BIIB icon
99
Biogen
BIIB
$30.4B
– –
-5,500
Closed -$1.6M
BKD icon
100
Brookdale Senior Living
BKD
$3.58B
– –
-557,000
Closed -$12.8M
2 3
4
5 6

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $8.5B AUM 25.14% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return

Deerfield Management's Q4 2015 Portfolio in Review

As of Q4 2015, Deerfield Management held 147 positions worth $2.47B, down 4.6% from $2.59B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Deerfield Management withdrew a net $497M in Q4 2015, closing 38 positions and reducing 28 holdings. Its most notable exit was bluebird bio, an estimated $41.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, down from 69% a quarter earlier, followed by Financials and Technology.

Against the trend, Deerfield Management opened a new position in Five Prime Therapeutics, Inc. worth $28.2M.

  • Deerfield Management's largest Q4 2015 buy was Five Prime Therapeutics, Inc.: 680,000 shares worth $28.2M.
  • Deerfield Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2015, an estimated $70.1M increase.
  • Deerfield Management's biggest Q4 2015 reduction was NxStage Medical Inc., cutting an estimated $32.2M.
  • Deerfield Management fully exited bluebird bio in Q4 2015, selling an estimated $41.3M.
  • Deerfield Management's ten largest holdings make up 35% of its $2.47B portfolio in Q4 2015.
  • Deerfield Management opened 13 new positions and closed 38 in Q4 2015.
  • Deerfield Management's portfolio value fell 4.6% quarter-over-quarter to $2.47B.

Based on Deerfield Management's 13F filing for Q4 2015, filed 16 Feb 2016.